Abstract
Background
Down syndrome (DS), the most common aneuploidy worldwide, is associated with metabolic anomalies affecting insulin and glucose regulation, increasing the risk of type 2 diabetes mellitus (T2DM). Despite this, adolescents with DS are often excluded from public health strategies, especially in low-resource settings where early screening and tailored interventions are limited. This study explores the association between DS and T2DM risk in adolescents in Veracruz, México, and highlights the urgent need to adapt inclusive prevention frameworks in public health systems.
Methods
A cross-sectional, prospective study was conducted in Veracruz, México; between September and December 2024, including adolescents aged 12-18. Those with diabetes or using medications that alter glucose or insulin metabolism were excluded. DS was the main independent variable. Dependent variables included T2DM risk, acanthosis nigricans (AN), high BMI, abdominal obesity, low physical activity, and poor diet, assessed via FINDRISC-A, PAQ-A and KIDMED (Cronbach's alpha: 0.84, 0.67, 0.79, respectively). Non-probability sampling was used. After ethics approval, informed consent was obtained from parents and adolescents. Data were analyzed using SPSS v.27.
Results
122 adolescents were included, 21 (17.2%) had DS. Overall, 25 participants (36.3%) had moderate to high T2DM risk. DS was significantly associated with elevated T2DM risk (OR: 5.91; 95% CI: 2.09-16.71; p < 0.001), AN (OR: 19.8; 95% CI: 3.65-107.3; p < 0.001), and abdominal obesity (OR: 3.17; 95% CI: 1.17-8.57; p = 0.01). No significant associations were found with physical activity or diet (p > 0.05).
Conclusions
Adolescents with DS show a clear metabolic vulnerability, underscoring the need for inclusive screening and early prevention. Public health systems must adapt to address atypical risk profiles and reduce health inequities for youth with disabilities.
Key messages
• Early detection of metabolic risk in adolescents with Down syndrome is crucial to prevent the early onset of type 2 diabetes and reduce long-term health disparities.
• Public health strategies must recognize Down syndrome as a metabolic risk group and implement inclusive, community-based screening and prevention programs.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Facultad de Medicina, Región Veracruz, Universidad Veracruzana, Veracruz, Mexico [email protected]





